{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:32:14Z","timestamp":1775093534213,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.jbspin.2009.01.001","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T10:17:40Z","timestamp":1237285060000},"page":"424-426","source":"Crossref","is-referenced-by-count":62,"title":["Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure"],"prefix":"10.1016","volume":"76","author":[{"given":"Nadia","family":"Announ","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaby","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Andr\u00e9","family":"Guerne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2009.01.001_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2174\/1381612053764922","article-title":"Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors","volume":"11","author":"Cheng","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jbspin.2009.01.001_bib2","article-title":"Colchicine prescribing and safety monitoring in patients with gout","volume":"120","author":"Ly","year":"2007","journal-title":"N Z Med J"},{"key":"10.1016\/j.jbspin.2009.01.001_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11926-008-0037-2","article-title":"Treating difficult crystal pyrophosphate dihydrate deposition disease","volume":"10","author":"Announ","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jbspin.2009.01.001_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jbspin.2007.04.004","article-title":"The inflammasome, autoinflammatory diseases, and gout","volume":"74","author":"Petrilli","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2009.01.001_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2009.01.001_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/art.23119","article-title":"Successful treatment of resistant pseudogout with anakinra","volume":"58","author":"McGonagle","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.01.001_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/BOR.0b013e3280145289","article-title":"Update in calcium deposition diseases","volume":"19","author":"Rosenthal","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2009.01.001_bib8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0083-6729(06)74016-X","article-title":"The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation","volume":"74","author":"Jacques","year":"2006","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jbspin.2009.01.001_bib9","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1016\/S0021-9258(19)76559-4","article-title":"Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor","volume":"263","author":"Black","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2009.01.001_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.jbspin.2009.01.001_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jbspin.2009.01.001_bib12","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.4049\/jimmunol.174.8.5016","article-title":"TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation","volume":"174","author":"Liu Bryan","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2009.01.001_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: role in biology","volume":"16","author":"Arend","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jbspin.2009.01.001_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.berh.2006.06.004","article-title":"Is IL-1 a good therapeutic target in the treatment of arthritis?","volume":"20","author":"Burger","year":"2006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2009.01.001_bib15","series-title":"Rheumatoid arthritis","first-page":"385","article-title":"Anakinra (interleukin-1 receptor antagonist)","author":"Arend","year":"2004"},{"key":"10.1016\/j.jbspin.2009.01.001_bib16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.22389","article-title":"Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis","volume":"56","author":"Chollet-Janin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.01.001_bib17","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/art.23552","article-title":"Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin, et al","volume":"58","author":"Tran Doan","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2009.01.001_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00002281-199905000-00012","article-title":"Molecular and cellular effects of methotrexate","volume":"11","author":"Seitz","year":"1999","journal-title":"Curr Opin Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X09000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T08:52:58Z","timestamp":1633251178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X09000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S1297319X09000190"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2009.01.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}